Search results for " monoclonal" in Articles / App Notes
								 					Article
				
				Multidimensional Scale-Up of a Monoclonal Antibody Capture Step, Using ÄKTA™ pilot 600
								
	Fast and efficient process development and scale-up contributes to a shortened time to market. In this work, a multidimensional scale-up (change of both column diameter and bed height) of a mAb capt…								
								 					Article
				
				Impact of Manufacturing-Scale Freeze-Thaw Conditions on a mAb Solution
								Nesta 
	Abstract 
	The objective of this study was to assess the impact of manufacturing-scale, freeze-thaw conditions on aggregation and subvisible particle formation of a monoclonal antibody sol…								
								 					Article
				
				Antibody Production in Microbial Hosts
								Rathore, Jyoti Batra 
	The biopharmaceutical industry is growing exponentially, driven by an ever-increasing demand for monoclonal antibodies (mAbs) and related products that are capable of treating…								
								 					Article
				
				Biopharma in 2015: A Year for Approvals and Innovations
								Immediately following its acquisition by Pfizer, Hospira announced a major milestone in February, 2015: its first monoclonal antibody (mAb) biosimilar was approved for use in West Europe.2 And in Nove…								
								 					Article
				
				Elucidating Biosimilars Characterization
								Compare this compound with the monoclonal antibody trastuzumab, which has a reported chemical formula of C6470H10012N1726O2013S42 and a molecular weight of 145531.50 g/mol, approximately 260 times the…								
								 					Article
				
				Re-use of Protein A Resin: Fouling and Economics
								Bracewell 
	
	BioPharm International 
	
	Volume 3, Issue 28 
	In the past two decades, Protein A affinity chromatography has remained the de facto capture step for purification of monoclonal antibod…								
								 					Article
				
				Addressing the Challenges in Downstream Processing Today and Tomorrow
								Coffman, Christopher Gallo, and Ranga Godavarti 
	
	ABSTRACT 
	
	In recent years, most pharmaceutical companies have focused on the development of monoclonal antibodies (mAbs). Increasing upstream t…								
								 					Article
				
				Digitalization: The Route to Biopharma 4.0
								Side-by-side Comparability of Batch and Continuous Downstream for the Purification of Monoclonal Antibodies. Biotechnol. Bioeng. 2020, 117 (4), 1024–1036. 
		
		19. Fisher, A. C.; Kamga, M. H.; Agarab…								
								 					Article
				
				Best Practices for Selecting a Top-Quality Cell Line
								Before scaling up to bioreactors, the productivity level for monoclonal antibodies (mAbs) should be 2–7 g/L (fed-batch culture in shake flask) or greater, observes Selexis CEO Igor Fisch. Once scaled …								
								 					Article
				
				Preclinical Evaluation of Product Related Impurities and Variants
								Two case studies—one involving a microbial therapeutic product (granulocyte colony stimulating factor)—and other—a mammalian therapeutic monoclonal antibody (bevacizumab) have been used to illustrate …